BRIEF-Saudi Chemical Says AJA Pharmaceutical Signs Non-Exclusive Agreement With Glaxo Saudi Arabia (GSK)

CHEMICAL
Tadawul All Shares Index

CHEMICAL

2230.SA

0.00

Tadawul All Shares Index

TASI.SA

0.00

June 16 (Reuters) - SAUDI CHEMICAL HOLDING 2230.SE:

  • SAUDI CHEMICAL - AJA PHARMACEUTICAL SIGNS NON-EXCLUSIVE AGREEMENT WITH GLAXO SAUDI ARABIA (GSK)

  • SAUDI CHEMICAL - ANNUAL VALUE OF CONTRACT EXPECTED TO BE LESS THAN 5% OF GROUP’S REVENUES

  • SAUDI CHEMICAL - AGREEMENT TO PROVIDE MEDICAL MARKETING SERVICES FOR A WIDE RANGE OF ITS PHARMACEUTICAL PRODUCTS IN SAUDI

  • SAUDI CHEMICAL - CONTRACT DURATION THREE YEARS, WITH AN OPPORTUNITY TO RENEW

  • SAUDI CHEMICAL - SERVICES WILL BE EXECUTED BY THE SPECIALIZED TEAMS OF AJA PHARMACEUTICAL INDUSTRIES COMPANY

  • SAUDI CHEMICAL - DEAL SUPPORTS STRATEGY TO EXPAND ITS CONTRACT SALES AND MEDICAL SERVICES CAPABILITIES IN SAUDI

  • SAUDI CHEMICAL - DEAL EXPECTED TO HAVE POSITIVE IMPACT ON THE COMPANY’S REVENUES COMMENCING FROM Q3 2026

  • SAUDI CHEMICAL - AGREEMENT WAS CONCLUDED ON AN ARM’S LENGTH BASIS AND IN THE ORDINARY COURSE OF BUSINESS

Source text: ID:nSSE6gGVyv

Further company coverage: 2230.SE


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.